Featured Research

from universities, journals, and other organizations

Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment

Date:
September 30, 2002
Source:
National Science Foundation
Summary:
Researchers have found a peptide molecule that triggers celiac sprue - a severe inflammation of the intestine that results from eating wheat and related grains - and propose a treatment strategy that relies on bacterial enzymes to break down the offending molecule in the digestive tract. As many as 1 in every 200 Americans suffers from the condition.

Researchers have found a peptide molecule that triggers celiac sprue - a severe inflammation of the intestine that results from eating wheat and related grains - and propose a treatment strategy that relies on bacterial enzymes to break down the offending molecule in the digestive tract. As many as 1 in every 200 Americans suffers from the condition.

In the September 27 issue of Science, Chaitan Khosla and his coworkers at Stanford University and the University of Norway in Oslo, report disassembling the large, complex mixture of gluten proteins and identifying a single component that triggers the autoimmune response characteristic of celiac sprue.

The study presents, "a combined chemical-physiological-immunological answer to the question 'why is gluten toxic to a person with celiac sprue?,'" said Khosla, whose work is supported by the National Science Foundation (NSF). "If proven correct, the findings will lead to new insights into the causes of celiac sprue, and perhaps certain other types of autoimmune diseases."

The researchers determined that the autoimmune response in people with celiac sprue can be traced to an unusually long molecule - a chain of 33 amino acids - that cannot be broken down by the human digestive system. They immersed the 33-amino acid chain in digestive enzymes derived from bacteria and found that a bacterial enzyme, prolyl endopeptidase, can break the chain into apparently harmless components.

"The technology used to isolate and identify the peptide trigger for celiac sprue, and the enzymology used to neutralize the disease, are marvelous examples of how research into the fundamental understanding of life processes can directly influence human health," said Fred Heineken, program director in NSF's Biochemical Engineering/Biotechnology Program.

Celiac sprue is often diagnosed only after years of painful symptoms. Presently, there is no cure. The only treatment is to completely avoid grains that contain gluten, such as wheat, rye and barley.

The disease usually surfaces in early childhood when intestinal tissue begins to show signs of devastation. Symptoms include chronic diarrhea and an inability to gain weight or grow normally. When the disease arises in adulthood, symptoms can also include fatigue, weight loss, anemia and neurological symptoms. Over time, celiac sprue can lead to overall sickness and even intestinal cancer.

In the small intestine, enzymes from the pancreas initially digest gluten by breaking it into a number of fragments called peptides. In most people, the larger peptides probably work their way down to the lower intestine where they are eaten by microorganisms.

"But in people with celiac sprue, the stable 33-amino acid peptide causes big problems because the molecule is recognized as being a threat to the person's immune system," said Khosla, who also received NSF's Alan T. Waterman Award in 1999. On learning that his family was faced with the illness, Khosla used the award to pursue research on the disease.

Khosla and his coworkers believe the bacterial enzymes, which worked in human tissue cultures as well as intact rats, may result in a simple, oral supplement that can eliminate the harmful effects of gluten. The treatment approach would be similar to enzyme supplements taken orally by people who cannot digest lactose, a sugar found in milk.

Khosla adds that an approved therapy could be as many as 5 to 8 years away, although research is already underway and the treatment should be testable in people within 2 to 3 years.

###

For a static illustration series of the disease process, see: http://www.nsf.gov/od/lpa/news/02/pr0277_image.htm

For more information on Celiac Sprue, see: http://www.nlm.nih.gov/medlineplus/celiacdisease.html

For more information on the Alan T. Waterman Award, see: http://www.nsf.gov/nsb/awards/waterman/waterman.htm


Story Source:

The above story is based on materials provided by National Science Foundation. Note: Materials may be edited for content and length.


Cite This Page:

National Science Foundation. "Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment." ScienceDaily. ScienceDaily, 30 September 2002. <www.sciencedaily.com/releases/2002/09/020927065040.htm>.
National Science Foundation. (2002, September 30). Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/2002/09/020927065040.htm
National Science Foundation. "Researchers Find Trigger For Devastating Digestive Disease, Propose Treatment." ScienceDaily. www.sciencedaily.com/releases/2002/09/020927065040.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Ebola Patient Told Hospital He Was from Liberia

Ebola Patient Told Hospital He Was from Liberia

AP (Oct. 1, 2014) The first Ebola patient diagnosed in the U.S. initially went to a Dallas emergency room last week but was sent home, despite telling a nurse that he had been in disease-ravaged West Africa, the hospital acknowledged Wednesday. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins